{
    "data": [
        {
            "id": "4558365",
            "title": "Paramount wins the bidding war for Warner Bros. as Netflix walks away",
            "description": "<html><body><p data-eci=\"true\"><span>Netflix (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/NFLX\" title=\"Netflix, Inc.\">NFLX</a></span>) announced that it will not raise its bid for </span><span>Warner Bros. Discovery</span><span> (<a href=\"https://seekingalpha.com/symbol/WBD\" title=\"Warner Bros. Discovery, Inc.\">WBD</a>) after the media giant's board deemed a sweetened, all‑company takeover offer from </span><span>Paramount Skydance</span><span> (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/PSKY\" title=\"Paramount Skydance Corporation\">PSKY</a></span>) as \"superior.\" </span></p>\n<p><span>The streaming company said a higher price for Warner Bros. (<a href=\"https://seekingalpha.com/symbol/WBD\" title=\"Warner Bros. Discovery, Inc.\">WBD</a>) was no longer financially attractive. The revised Paramount (<a href=\"https://seekingalpha.com/symbol/PSKY\" title=\"Paramount Skydance Corporation\">PSKY</a>) offer was at a purchase price of $31.00 per share in cash, a one-dollar increase from its earlier bid, which valued the company at around $108B.</span></p>\n<p><span>\"This year, we'll invest approximately $20 billion in quality films and series and will expand our entertaining offering. Consistent with our capital allocation policy, we'll also resume our share repurchase program,\" read a statement from Netflix (<a href=\"https://seekingalpha.com/symbol/NFLX\" title=\"Netflix, Inc.\">NFLX</a>).</span></p>\n<p><span>Shares of Netflix (<a href=\"https://seekingalpha.com/symbol/NFLX\" title=\"Netflix, Inc.\">NFLX</a>) soared 10.2% in postmarket trading as investors looked at the development as a positive. Warner Bros. Discovery (<a href=\"https://seekingalpha.com/symbol/WBD\" title=\"Warner Bros. Discovery, Inc.\">WBD</a>) fell 2.2% in the late session, while Paramount Skydance (<a href=\"https://seekingalpha.com/symbol/PSKY\" title=\"Paramount Skydance Corporation\">PSKY</a>) was 3.8% higher.</span></p>\n<p> </p>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4558365-paramount-wins-the-bidding-war-for-warner-bros-as-netflix-walks-away",
            "pub_date": "2026-02-27 07:41:37",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4558376",
            "title": "Service Properties Trust outlines $500M-$520M adjusted EBITDAre guidance for 2026 amid continued asset sales and debt reduction",
            "description": "<html><body><p data-eci=\"true\">Earnings Call Insights: Service Properties Trust (SVC) Q4 2025</p>\n<h3>Management View</h3>\n<ul>\n<li>Christopher Bilotto, President and CEO, highlighted the completion of hotel sales and active steps to reduce leverage, stating, \"During the quarter, we sold 66 hotels totaling nearly 8,300 keys for $534 million.\" He emphasized that the company used proceeds and cash on hand to redeem all $800 million of 2026 debt maturities and $300 million of February 2027 notes, adding, \"We remain focused on selling additional hotels and executing further strategies to improve SVC's cash flows, debt maturity profile and overall cost of capital.\"</li>\n<li>Bilotto announced the sale of Simply Suites for $7.1 million and the marketing of 9 focused service hotels and 7 full-service Sonesta managed hotels, aiming for total proceeds of $175 million to $200 million, with the sales expected to increase annual EBITDA by about $13 million and improve leverage metrics.</li>\n<li>The CEO detailed a new $745 million, 5-year mortgage financing, secured by the net lease master trust, with an expected annual cash savings of $14 million or $0.08 per share due to a lower interest rate.</li>\n<li>Bilotto noted, \"SVC's portfolio continued to deliver steady top line growth as RevPAR increased 70 basis points year-over-year, outpacing the broader industry by 180 basis points and representing the fifth consecutive quarter of outperformance.\"</li>\n<li>The appointment of Keith Pierce and Jeff Leer as Co-CEOs of Sonesta, effective April 1, was announced, with Bilotto stating, \"We believe their leadership and experience will be instrumental in further optimizing Sonesta RevPAR market share performance while driving operational discipline.\"</li>\n<li>Jesse Abair, Vice President, reported that 2025 acquisitions totaled $101 million, with a net lease portfolio of 760 properties and annual base rents of $390 million, noting an average rent coverage of 2.7x and a 97% lease rate. He stated, \"Annualized base rent increased 2.4%, largely a function of our recent acquisition activity.\"</li>\n<li>Brian Donley, CFO, said, \"Normalized FFO was $27.5 million or $0.17 per share, flat compared to the prior year quarter. Adjusted EBITDAre decreased $5 million year-over-year to $125.6 million.\"</li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li>SVC introduced full year 2026 guidance, projecting RevPAR of $108 to $113 and hotel EBITDA of $124 million to $144 million for 94 hotels owned at year-end. Net lease NOI is expected between $380 million and $386 million.</li>\n<li>Consolidated adjusted EBITDAre is forecasted at $500 million to $520 million, with normalized FFO per share of $0.65 to $0.77. CapEx is projected at $120 million to $140 million, with free cash flow generation after CapEx anticipated for 2026.</li>\n<li>Management noted, \"This guidance does not reflect the impact of completing 17 Sonesta hotel dispositions, and it assumes $25 million of capital recycling in our net lease portfolio.\"</li>\n</ul>\n<h3>Financial Results</h3>\n<ul>\n<li>For Q4 2025, normalized FFO was $27.5 million or $0.17 per share, and adjusted EBITDAre was $125.6 million.</li>\n<li>Comparable hotel RevPAR rose by 70 basis points, while the gross operating profit margin declined by 370 basis points to 20.5%.</li>\n<li>The hotel portfolio generated adjusted hotel EBITDA of $21.3 million, a 35% decrease year-over-year, attributed to elevated labor and overhead costs, and the absence of prior year business interruption insurance.</li>\n<li>At quarter-end, debt stood at $5.2 billion with a weighted average interest rate of 5.95%.</li>\n<li>CapEx for Q4 was $106 million, with a full year total of $238 million, including major projects at the Nautilus in Miami and other Sonesta properties.</li>\n</ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li>Jackson Armstrong, Wells Fargo: Asked about RevPAR trends and the width of guidance. Brian Donley responded, \"We're tracking in line, if not exceeding our projections for the full year guidance,\" citing portfolio volatility and citywide events as reasons for the broader guidance range.</li>\n<li>Armstrong: Inquired about the strategic shift in net lease acquisitions. Christopher Bilotto explained, \"The $25 million guidance will be supported by sales of net lease properties, so kind of net 0 in that standpoint.\"</li>\n<li>Armstrong: Sought expense growth detail. Donley said, \"Overall, to the midpoint, just top line is a little over 4% expectation on growth. The bottom line, we're seeing around 6% and a big part of that is labor.\"</li>\n<li>Armstrong: Questioned the impact of new Sonesta management. Bilotto stated, \"Certainly, with this management team coming in... we view it as a positive... I think they'll do just that.\"</li>\n<li>Tyler Batory, Oppenheimer: Asked about RevPAR and portfolio quality. Donley indicated, \"The guidance and the growth trajectory, the midpoint RevPAR is around $110, which is a 3% RevPAR growth.\"</li>\n<li>Batory: Probed margin and CapEx outlook. Donley detailed, \"$120 million to $140 million is a big step for us. The pace of large significant renovations are winding down. The Nautilus is definitely the biggest piece of this year.\"</li>\n<li>Batory: Asked about debt headroom and maturities. Donley responded, \"Not a lot of headroom for a large transaction, but... the 0 coupons are already secured by assets.\"</li>\n<li>John Massocca, B. Riley: Focused on hotel dispositions and EBITDA impact. Bilotto confirmed, \"The 9 focused service that are part of the 16 we're in the market with are the carryover from 2025.\"</li>\n<li>Massocca: Asked about EBITDA mix and unencumbered assets. Donley replied, \"It's not too far off from high-60s to low-30s from an EBITDA mix.\"</li>\n<li>Massocca: Sought clarification on net lease coverage. Bilotto said, \"The coverage drop is largely a function of TA coverage dropping 7 basis points quarter-over-quarter... But in the meantime... those leases are backed by BP credit.\"</li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li>Analysts maintained a neutral tone, with questions focused on guidance ranges, the impact of leadership changes, and capital deployment. There was a persistent emphasis on expense pressures, asset sales, and debt management, but without overt skepticism or negative language.</li>\n<li>Management's tone in prepared remarks was cautiously optimistic, highlighting \"continued progress\" and \"momentum\" while acknowledging challenges such as \"elevated labor costs\" and \"operational disruption.\" During the Q&amp;A, responses remained measured, with confidence in strategy but no overstatement of positive outcomes. Phrases like \"we feel confident\" and \"we believe\" indicated a balanced outlook.</li>\n<li>Compared to the previous quarter, both management and analysts maintained a similar pragmatic stance, with management slightly more upbeat about the impact of recent asset sales and refinancing, while analysts continued to press on execution and margin risks.</li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li>Guidance for 2026 is more detailed, with explicit projections for RevPAR, hotel EBITDA, net lease NOI, and adjusted EBITDAre, whereas Q3 focused more on near-term asset sales and debt reduction.</li>\n<li>The pace of hotel dispositions continued, but there is a clear shift toward winding down large-scale CapEx and focusing on free cash flow generation, versus Q3's emphasis on major renovations and capital deployment.</li>\n<li>Analyst questions in both quarters centered on asset sales, debt strategy, margin outlook, and CapEx discipline, but Q4 saw increased focus on execution timing for asset sales and the impact of Sonesta's new management.</li>\n<li>Management's confidence increased regarding the transition to a stronger debt profile and the benefits of recent refinancing, while reiterating caution on labor and operational costs.</li>\n<li>The shift in strategic priorities is evident in the more conservative net lease acquisition target and a deliberate reduction in hotel CapEx.</li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li>Management cited \"elevated labor costs and broader operating expense pressures\" and \"temporary operational disruption\" from hotel dispositions as headwinds.</li>\n<li>The CEO cautioned about \"the impact of the prolonged government shutdown\" and \"value-conscious customers remain sensitive to broader macroeconomic conditions.\"</li>\n<li>The net lease portfolio's coverage ratio saw a small drop, attributed to the TA assets, though these are backed by BP's credit.</li>\n<li>Analysts raised concerns about the breadth of RevPAR guidance, margin pressures from labor and benefits, and the execution risk of planned asset sales.</li>\n<li>Management's mitigation strategies included targeting hotel sales to improve EBITDA, focusing on high-performing renovated assets, and using proceeds to reduce debt and interest costs.</li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>Service Properties Trust's fourth quarter call outlined continued portfolio optimization, major debt reduction initiatives, and a cautious approach to capital deployment. Management signaled confidence in achieving $500 million to $520 million in adjusted EBITDAre for 2026 and expects free cash flow generation following a period of elevated capital investment. The company plans to further reduce leverage through targeted asset sales, focus on operational discipline, and maintain a stable net lease platform, while remaining attentive to cost pressures and market volatility.</p>\n<p><a href=\"https://seekingalpha.com/symbol/svc/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4558376-service-properties-trust-outlines-500m-520m-adjusted-ebitdare-guidance-for-2026-amid",
            "pub_date": "2026-02-27 07:41:37",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4558371",
            "title": "Indivior outlines 30% adjusted EBITDA growth target for 2026 with new $400M share repurchase program",
            "description": "<html><body><p data-eci=\"true\">Earnings Call Insights: Indivior Pharmaceuticals, Inc. (INDV) Q4 2025</p>\n<h3>Management View</h3>\n<ul>\n<li><p>CEO Joseph Ciaffoni stated that 2025 was a transition year, highlighting the successful completion of Phase I Generate Momentum and the delivery of record net revenue for SUBLOCADE of $856 million, a 13% increase versus 2024, and total net revenue of $1.24 billion, up 4% from the prior year. He emphasized, \"We improved our commercial execution and generated momentum for SUBLOCADE, delivering record net revenue in 2025 of $856 million, a 13% increase versus 2024 and total net revenue of $1.24 billion, representing a 4% increase compared to the prior year.\" Ciaffoni announced the completion of the $295 million DOJ obligation payment and introduced a new $400 million share repurchase program. He described the shift to Phase II of the Indivior Action agenda, Accelerate, projecting accelerated SUBLOCADE dispense unit growth and net revenue in 2026, with immediate growth in adjusted EBITDA and cash flow.</p></li>\n<li><p>Chief Commercial Officer Patrick Barry reported, \"In the fourth quarter, we delivered strong dispense unit growth of 12% versus the prior year and 6% versus the third quarter. New patient starts in the fourth quarter were up 25% year-over-year.\" Barry noted record levels in active SUBLOCADE prescribers and outlined improvements in field force messaging, commercial channel productivity, patient activation, and policy engagement.</p></li>\n<li><p>CFO Ryan Preblick stated, \"We delivered on our financial commitments in 2025. We grew total SUBLOCADE net revenue by 13% and adjusted EBITDA by 20% year-over-year, and we simplified the organization while strengthening our financial profile.\" Preblick also highlighted the authorization of the new $400 million share repurchase program and reaffirmed 2026 financial guidance.</p></li>\n</ul>\n<h3>Outlook</h3>\n<ul><li>The company reaffirmed 2026 guidance with total net revenue expected in the range of $1.125 billion to $1.195 billion, reflecting a modest decline at the midpoint due to anticipated SUBOXONE Film pressure and lower international revenue. SUBLOCADE net revenue is projected between $905 million and $945 million, representing 8% growth at the midpoint. Adjusted EBITDA is expected between $535 million and $575 million, a 30% increase at the midpoint, with margin expansion to 48%. Operating expenses are guided between $430 million and $450 million. Ciaffoni said, \"We expect to deliver SUBLOCADE dispense unit growth in the mid-teens, an acceleration compared to the 7% dispense unit growth we achieved in 2025.\"</li></ul>\n<h3>Financial Results</h3>\n<ul><li>Fourth quarter total net revenue reached $358 million, up 20% year-over-year, led by SUBLOCADE net revenue of $252 million for the quarter, a 30% increase. Full year SUBLOCADE dispense volume grew 7%. Adjusted EBITDA for Q4 increased 91% to $142 million, and for the full year rose 20% to $428 million with a 500 basis point margin improvement. Fourth quarter operating expenses were $164 million; full year operating expenses totaled $622 million, both down versus the prior year. The company ended the year with $222 million in gross cash and investments after settling the DOJ obligation.</li></ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li><p>David Amsellem, Piper Sandler: Asked about LAI buprenorphine penetration, market share, and capital deployment priorities. Ciaffoni responded that LAI penetration is at 9%, with analogs in schizophrenia suggesting potential for 20% to 30%. He emphasized a focus on new patient share and stated, \"From a share perspective, we have seen over many quarters, our market share stabilizing in the mid-70%.\" On capital deployment, Ciaffoni emphasized targeting commercial-stage assets with over $200 million peak sales potential and a long runway; \"We're looking for assets that have peak sales potential of greater than $200 million.\"</p></li>\n<li><p>Chase Knickerbocker, Craig-Hallum: Inquired about assumptions behind 2026 guidance and capital allocation between buybacks and M&amp;A. Ciaffoni said, \"We're assuming mid-teens SUBLOCADE growth,\" and Preblick explained, \"We authorized the $400 million program to be ready to be prepared to buy back shares and be opportunistic.\"</p></li>\n<li><p>Yuchen Ding, Jefferies: Asked about Medicaid funding risks and SG&amp;A trends. Ciaffoni avoided specifics on DTC spend and Medicaid outlook for 2027 but noted current penetration leaves ample room for growth regardless of Medicaid fluctuations. Preblick clarified the Q4 SG&amp;A step-up was due to the DTC campaign, with relatively flat expense phasing in 2026.</p></li>\n<li><p>Christian Glennie, Stifel: Clarified reconciliation of SUBLOCADE guidance and impacts from gross-to-net. Ciaffoni said, \"In 2025, gross to net served as a tailwind. In 2026, gross to net will serve as a headwind to the business.\"</p></li>\n<li><p>Brandon Folkes, H.C. Wainwright: Asked about the criminal justice system's role in guidance. Barry responded the segment is \"a rebased business\" contributing to overall expected growth.</p></li>\n<li><p>Thibault Boutherin, Morgan Stanley: Asked about ex-U.S. SUBLOCADE and R&amp;D impacts. Preblick indicated rest-of-world SUBLOCADE revenue will be \"relatively flat year-over-year,\" with growth in Australia and Canada offset by the Nordics. Heidbreder detailed timelines for two Phase II trial readouts and outlined criteria for potential Phase III advancement.</p></li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li><p>Analysts pressed on growth drivers, market share, capital deployment, Medicaid risk, SG&amp;A, and the reconciliation of guidance metrics, reflecting a neutral to slightly positive tone with several requests for clarification on strategic priorities and market opportunity.</p></li>\n<li><p>Management maintained a confident and disciplined tone, particularly around SUBLOCADE’s growth prospects, capital deployment, and cost controls. Phrases such as \"we are confident\" and \"we expect\" were prevalent in prepared remarks, while responses in Q&amp;A avoided specifics but underscored strategic focus and financial discipline.</p></li>\n<li><p>Compared to the previous quarter, analyst sentiment remains consistent, with continued focus on growth levers, commercial execution, and cost management. Management’s confidence appears to have increased, with stronger emphasis on financial strength and capital allocation optionality.</p></li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li><p>Guidance language has shifted from projecting growth to reaffirming specific 2026 financial targets, including an 8% SUBLOCADE net revenue growth midpoint and 30% adjusted EBITDA growth. Strategic focus has moved from completing organizational simplification to emphasizing commercial acceleration and capital deployment.</p></li>\n<li><p>Analysts maintain focus on SUBLOCADE growth drivers and market share, while also probing capital allocation and operating cost discipline. Key metrics such as SUBLOCADE net revenue and adjusted EBITDA show acceleration from previous guidance.</p></li>\n<li><p>Management’s tone is more assertive and confident, referencing the completion of Phase I and a pivot to Phase II Accelerate, with greater clarity on share repurchase and M&amp;A strategy. Analysts’ tone remains questioning but constructive, seeking greater detail on execution and risk factors.</p></li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li><p>Management highlighted gross-to-net headwinds in 2026, the expected decline in SUBOXONE Film revenue, and potential volatility in Medicaid funding as areas of concern. Ciaffoni stated, \"At 8%, 9% long-acting injectable penetration, there is so much opportunity for growth with SUBLOCADE across the board, inclusive of Medicaid, it will not be impacted whether Medicaid population is plus or minus a certain percentage.\"</p></li>\n<li><p>Analysts asked about the impact of Medicaid funding, the reconciliation of guidance metrics, and the role of the criminal justice system. Management’s responses stressed the underutilization of long-acting injectables and a broad opportunity for SUBLOCADE growth.</p></li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>Indivior’s leadership outlined a clear transition from organizational restructuring to commercial acceleration in 2026, underpinned by a new share repurchase program and guided by targeted investment in SUBLOCADE and potential business development. The company projects mid-teens SUBLOCADE unit growth, 8% net revenue growth for the product, and a 30% increase in adjusted EBITDA, supported by ongoing cost controls and a disciplined capital allocation strategy. Management’s confidence in SUBLOCADE’s durability and the company’s financial strength sets the stage for executing on Phase II of its action agenda.</p>\n<p><a href=\"https://seekingalpha.com/symbol/indv/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4558371-indivior-outlines-30-percent-adjusted-ebitda-growth-target-for-2026-with-new-400m-share",
            "pub_date": "2026-02-27 07:30:47",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4558372",
            "title": "Ellington Financial targets further portfolio growth and liability optimization through expanded securitization and strategic acquisitions",
            "description": "<html><body><p data-eci=\"true\">Earnings Call Insights: Ellington Financial Inc. (EFC) Q4 2025</p>\n<h3>Management View</h3>\n<ul>\n<li>Laurence Penn, CEO, opened the call stating, \"Ellington Financial closed out 2025 on a high note, capping a year of consistently strong performance, portfolio growth and liability optimization.\" He highlighted that adjusted distributable earnings (ADE) of $0.47 per share \"continued to substantially exceed our dividends,\" and attributed results to \"exceptional performance and execution in our loan origination and securitization platforms with outsized contributions once again from our Longbridge segment.\" </li>\n<li>Penn announced a $400 million unsecured notes offering, describing it as \"our largest to date, marking a significant step forward in the evolution of our capital structure.\" He explained that proceeds were partly used to reduce short-term repo financing and further expand the investment portfolio by 9%. </li>\n<li>Penn detailed the completion of seven securitizations in Q4, including the first residential transition loans (RTL) securitization with a revolving structure, and the first agency-eligible mortgage securitization post year-end, expanding the EFMT branded shelf to five residential loan sectors. He emphasized, \"this expansion allows us to term out financing across all of our major residential loan strategies on a nonrecourse, non-mark-to-market basis... further enhancing balance sheet resilience and capital efficiency.\" </li>\n<li>Penn revealed a targeted common equity raise in January 2026, sized precisely to redeem the highest-cost Series A preferred stock. \"The coupon on our Series A preferred stock was over 9%. So starting tomorrow... our common shareholders will immediately see the benefit of a lower overall cost of capital.\"</li>\n<li>CFO JR Herlihy stated, \"For the fourth quarter, we reported GAAP net income of $0.14 per common share on a fully mark-to-market basis and ADE of $0.47 per share.\" He added, \"Net interest income increased sequentially and we also generated net realized and unrealized gains on non-QM retained tranches and forward MSR-related investments.\" </li>\n<li>Herlihy noted, \"Unencumbered assets... increased 45% to $1.77 billion, which was about 90% -- 95% of total equity.\" He also said, \"the share of long-term non-mark-to-market financings increased to 30% from 17% and the share of unsecured borrowings increased to 18% from 8%.\"</li>\n<li>Co-Chief Investment Officer Mark Tecotzky reported, \"We continue to execute our loan origination to securitization playbook, completing 7 securitizations in Q4 across a variety of loan types and that momentum has carried into 2026.\"</li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li>Management stated, \"Our priorities for 2026 are clear. We are focused on growing our loan origination market share while maintaining strong credit performance, which, together with our securitization platform should drive disciplined portfolio growth.\"</li>\n<li>Penn indicated, \"We are estimating that EFC generated an economic return of approximately 2% in January, with loan production and portfolio growth remaining strong, particularly in our non-QM, commercial mortgage bridge and reverse mortgage loan businesses.\"</li>\n<li>Penn highlighted the pending acquisition of a small residential mortgage servicer, which \"will further enhance our vertical integration by bringing more servicing capabilities in-house, especially for delinquent assets.\"</li>\n</ul>\n<h3>Financial Results</h3>\n<ul>\n<li>The company reported GAAP net income of $0.14 per common share and ADE of $0.47 per share for Q4.</li>\n<li>Portfolio income breakdown as stated by Herlihy: $0.35 per share from Credit, $0.04 from Agency, and $0.15 from Longbridge.</li>\n<li>ADE breakdown: $0.61 per share from the Investment Portfolio segment and $0.13 from the Longbridge segment.</li>\n<li>The adjusted long credit portfolio increased 15% to $4.1 billion quarter-over-quarter.</li>\n<li>Unencumbered assets grew 45% to $1.77 billion; recourse debt-to-equity ratio was 1.9:1 (up from 1.8:1); overall debt-to-equity ratio increased to 9:1 from 8.6:1.</li>\n<li>Book value per share at year-end was $13.16; economic return for Q4 was 4.6% annualized.</li>\n</ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li>Douglas Harter, UBS: Asked about the decision to buy the servicer and whether it changes asset appetite or is about optimizing the existing portfolio. Mark Tecotzky responded that consolidation in the servicing industry left few high-touch servicing options and stated, \"our plan is to build out the technology with the servicer,\" aiming for \"best-in-class protocols and best-in-class workflow.\" Penn clarified, \"Owned within EFC.\"</li>\n<li>Harter followed up on whether the servicer could serve third parties. Tecotzky replied, the initial focus is on building technology and protocols for EFC, with potential to serve others later.</li>\n<li>An analyst from BTIG asked about repo conditions for retained tranches. Tecotzky explained, \"Repo market functioned extremely well... Financing spreads on retained tranches are... relatively low.\" He noted, \"we tend to operate the company very conservatively when it comes to repo\" and do not plan to add more leverage to those tranches.</li>\n<li>Trevor Cranston, Citizens JMP, inquired about Agency-eligible market policy risks. Tecotzky described monitoring for LLPA and G-fee changes, noting, \"a fairly significant change... would be needed to swing the pendulum back over to GSE execution.\"</li>\n<li>Francesco Labetti, KBW, asked about origination competition and margins. Tecotzky stated, \"the market is always competitive, but... you could still price things with the margin and retain things at attractive yields.\" Penn added about reverse mortgages: \"Longbridge is... always in the top 3 originators in the HECM space... margins are excellent and volumes are... quite steady and growing.\"</li>\n<li>Labetti also asked about bank capital standards and mortgage market activity. Tecotzky observed, \"bank support for the mortgage market in 2025\" was \"shockingly underwhelming,\" expecting potential changes from new regulations.</li>\n<li>Timothy D'Agostino, B. Riley, asked for top 2026 priorities. Penn prioritized covering the dividend, strengthening liability structure, supporting originator affiliates, managing delinquencies, and portfolio growth. Herlihy added, \"leverage has actually declined... from 2.3 to 1.9\" while portfolio size doubled in two years.</li>\n<li>Jason Weaver, JonesTrading, prompted on future leverage and securitization pace. Herlihy responded, \"intra-quarter... recourse debt to equity, it fluctuates,\" but projected more expansion with \"additional unsecured note offerings.\"</li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li>Analysts' tone was neutral to slightly positive, focusing on execution details, risk mitigation, and strategic priorities. Questions were probing but not adversarial, with a consistent focus on portfolio growth, capital structure, and servicing integration.</li>\n<li>Management maintained a confident, constructive tone, emphasizing resilience, adaptability, and proactive capital optimization. Penn and Tecotzky frequently referenced deliberate strategic actions and disciplined risk management, using phrases such as \"we continue to execute\" and \"we are focused on growing.\"</li>\n<li>Compared to the previous quarter, both analysts and management showed increased confidence, especially around balance sheet strength and vertical integration, while remaining attentive to market risks.</li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li>Guidance language shifted to emphasize continued earnings strength into 2026, portfolio expansion, and vertical integration through the pending servicer acquisition.</li>\n<li>The previous quarter's emphasis on deploying note proceeds and adding agency-eligible mortgage exposure evolved into concrete securitization activity and broader liability optimization this quarter.</li>\n<li>Analysts' focus moved from questions about deployment of new capital and non-QM growth to more detailed queries on servicing strategy, leverage, and competitive positioning.</li>\n<li>Management's tone turned more proactive regarding capital structure and strategic acquisitions, with explicit reference to dividend coverage consistency and expanded technology initiatives.</li>\n<li>Key metrics such as ADE per share and portfolio size remained strong, though net income per share declined from Q3 to Q4.</li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li>Management cited \"heightened policy uncertainty, potential restrictions on institutional purchases of single-family rentals, GSE reductions, LLPA changes and mortgage insurance premium cuts\" as ongoing risks.</li>\n<li>Tecotzky highlighted challenges with bank loans and a modest drag from the CLO portfolio, as well as underperformance in RTL due to securitization costs and REO workouts, though \"delinquencies there remain quite manageable.\"</li>\n<li>The company is monitoring the housing market for \"broader signs of weakness\" and maintaining significant credit hedges.</li>\n<li>Analysts questioned the competitive environment, credit risk, and impact of regulatory shifts, with management emphasizing conservative leverage and risk management protocols.</li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>Ellington Financial's fourth quarter showcased robust portfolio expansion, effective capital structure optimization, and enhanced vertical integration initiatives. Management highlighted consistent dividend coverage by distributable earnings, a strengthened liability profile through increased non-mark-to-market and unsecured financing, and strategic moves into servicing. The company's focus on disciplined growth, risk management, and technology-backed origination positions it for continued resilience and earnings stability into 2026, while remaining vigilant to evolving market and policy risks.</p>\n<p><a href=\"https://seekingalpha.com/symbol/efc/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4558372-ellington-financial-targets-further-portfolio-growth-and-liability-optimization-through",
            "pub_date": "2026-02-27 07:30:47",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4558362",
            "title": "TotalEnergies inks 20-year offtake deal with Alaska LNG project",
            "description": "<html><body><p data-eci=\"true\">TotalEnergies (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/TTE\" title=\"TotalEnergies SE\">TTE</a></span>) said Thursday it <a href=\"https://totalenergies.com/news/press-releases/united-states-totalenergies-signs-agreement-export-2-mtpa-lng-20-years-alaska\" rel=\"nofollow\" target=\"_self\" title=\"signed\">signed</a> a <span>preliminary agreement</span> to purchase 2M metric tons/year of liquefied natural gas for 20 years from Glenfarne's Alaska LNG project, <span>marking another step toward commercializing the proposed 20M tons/year export facility.</span></p>\n<p><span>The letter of intent was signed at a ceremony in Washington, D.C., with Alaskan elected officials in attendance.</span></p>\n<p><span>\"<span>The Alaska LNG project is indeed very well geographically positioned to better serve our Asian customers,\" TotalEnergies (<a href=\"https://seekingalpha.com/symbol/TTE\" title=\"TotalEnergies SE\">TTE</a>) Chairman and CEO Patrick Pouyanne said. \"It also illustrates TotalEnergies' ambition to consolidate its position as a leading buyer of U.S. LNG while diversifying its supply sources.\"</span></span></p>\n<p><span><span>TotalEnergies (<a href=\"https://seekingalpha.com/symbol/TTE\" title=\"TotalEnergies SE\">TTE</a>) said the deal is subject to the project's final investment decision, which Glenfarne said would happen when it contracts for 16M tons/year for the project.</span></span></p>\n<p><span><span>Glenfarne said it now has 13M tons/year covered under preliminary long-term agreements with TotalEnergies (<a href=\"https://seekingalpha.com/symbol/TTE\" title=\"TotalEnergies SE\">TTE</a>), JERA, Tokyo Gas, CPC, PTT and Posco.</span></span></p>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4558362-totalenergies-inks-20-year-offtake-deal-with-alaska-lng-project",
            "pub_date": "2026-02-27 07:20:48",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4558363",
            "title": "Chesapeake Utilities reaffirms $7.75–$8 EPS target for 2028 as it launches $75M ERP transformation and advances Florida rate case",
            "description": "<html><body><p data-eci=\"true\">Earnings Call Insights: Chesapeake Utilities Corporation (CPK) Q4 2025</p>\n<h3>Management View</h3>\n<ul>\n<li>Jeffrey Householder, President, CEO &amp; Chairman, highlighted \"2025 was our 19th consecutive year of earnings growth,\" with adjusted earnings of $6.01 per share, a 12% increase over 2024. He emphasized, \"We invested $470 million through 2025, a 32% increase over our 2024 capital spend and $20 million above our 2025 guidance range.\" Above-average residential growth of 3% was cited as the primary driver for the capital program, and nearly 11,000 new customers were added in 2025 across natural gas and electric areas. He announced, \"We're initiating full year 2026 capital expenditure guidance of $450 million to $500 million... including successful completion of a number of projects and initiating construction on a new set of opportunities.\"</li>\n<li>Householder introduced a new technology transformation, stating, \"We're undertaking the largest technology system implementation in our history with our multiyear enterprise resource plan or ERP... which we're calling 1CORE is going to be bigger and even more transformational than anything we've done thus far.\"</li>\n<li>He also announced the Delmarva Regional Enhancement project with an estimated capital investment of $75 million and an in-service date around the end of 2028, and a $6.5 million grant-backed feasibility study for new Virginia infrastructure.</li>\n<li>Beth Cooper, Executive VP, CFO, Treasurer &amp; Assistant Corporate Secretary, stated, \"We generated approximately $639 million of adjusted gross margin, $141 million of adjusted net income and $6.01 of adjusted earnings per share in 2025, all representing double-digit increases over full year 2024.\" She added, \"We ended 2025 at an equity capitalization of 50%, meeting the goal we set at the start of the year, 3 years ahead of the target.\" She reaffirmed the 2028 adjusted EPS range of $7.75 to $8 per share and long-term growth target of 8%.</li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li>The company reaffirmed its 2028 adjusted EPS guidance of $7.75 to $8 per share and outlined a 2026 capital plan of $450 million to $500 million. Cooper reiterated, \"We are reaffirming our 2028 adjusted EPS range of $7.75 to $8 per share as we remain on track to meet our long-term adjusted EPS growth target of 8%.\"</li>\n<li>Management discussed the upcoming general rate case for Florida City Gas, with expectations for interim rates by early July 2026 and an improved allowed ROE.</li>\n</ul>\n<h3>Financial Results</h3>\n<ul>\n<li>Cooper reported, \"Adjusted net income was up 16%, which translated into a 12% increase in adjusted EPS after we purposely advanced our equity to total capitalization ratio back to 50%.\" Regulated segment adjusted gross margin was $494 million in 2025, a 12% increase over 2024, and regulated operating income rose 13% to approximately $222 million.</li>\n<li>The unregulated segment delivered $145 million in adjusted gross margin, up 13% year-over-year, with Marlin Gas Services driving $11 million of additional gross margin.</li>\n<li>Dividend policy was highlighted, with an annualized dividend per share of $2.74, a 7% increase from 2024, and a payout ratio enabling 54% of earnings to be retained for reinvestment.</li>\n</ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li>Michael Brown, Barclays: Asked for a walk-through of the growth rate from 2025 to 2028. Cooper replied, \"We have reaffirmed our 2028 EPS guidance... we've historically provided long-term EPS guidance given some of the capital expenditures that we incur... our long-term EPS CAGR of 8%.\"</li>\n<li>Christopher Ellinghaus, Siebert Williams Shank: Inquired about weather impacts in Q1 and growth in FCG customers. Cooper responded, \"In Delaware, there will certainly be an impact, and we've begun to quantify the first part of that for January... there will also be some, to your point, that may come from certainly the propane side as well down there.\"</li>\n<li>Ellinghaus also asked about ERP benefits. Householder explained, \"There are opportunities on the customer service side... reducing the number of calls to our call centers, automatic meter reading... significant opportunities there.\"</li>\n<li>Paul Fremont, Ladenburg: Asked about adjusted gross margin from Marlin and RNG projects. Cooper clarified, \"The line that you're looking at is actually a compilation of Marlin, Full Circle Dairy and our Noble RNG project... a big part of the growth... is actually coming more from Marlin.\"</li>\n<li>Alexis Kania, BTIG: Sought color on Delmarva growth and FCG debt refinancing. Cooper said, \"We continue to actually see strong growth in Delaware... there's a lot of planned also infrastructure growth, particularly in the Southern County of Delaware.\"</li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li>Analysts raised detailed questions regarding growth rates, weather impacts, project specifics, and regulatory developments, reflecting a neutral to slightly positive tone, with interest in sustainability of growth and cost controls.</li>\n<li>Management maintained a confident tone in both prepared remarks and Q&amp;A, consistently reaffirming guidance and capital plans. Householder and Cooper provided detailed responses and emphasized execution of strategic priorities, using language such as \"We remain committed\" and \"We are reaffirming our... guidance.\"</li>\n<li>Compared to the previous quarter, management's tone remains confident, with analysts maintaining a neutral stance, shifting to more granular questions about capital allocation and regulatory risks.</li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li>The company moved from annual EPS guidance for 2025 in Q3 to reaffirming only long-term 2028 EPS targets in Q4, while providing a specific 2026 capital expenditure range.</li>\n<li>Strategic focus shifted to accelerating technology transformation with the 1CORE ERP launch and highlighting new major projects (Delmarva Regional Enhancement and Virginia infrastructure study), compared to Q3’s focus on ongoing projects and regulatory filings.</li>\n<li>Analysts in Q4 concentrated on long-term outlook, regulatory events, and operational details, versus Q3’s focus on immediate guidance and project throughput.</li>\n<li>Key metric changes include a reported 12% full-year EPS growth and achieving a 50% equity capitalization target three years ahead of schedule.</li>\n<li>Management’s confidence remained high, with repeated emphasis on execution and growth, while analysts continued to probe for clarity on operational and regulatory developments.</li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li>Management cited the Florida City Gas depreciation study outcome as a headwind, stating, \"We were unable to repeat [the RSAM benefit] given the outcome of the Florida City Gas depreciation study.\"</li>\n<li>Cooper noted increased operating expenses and financing costs partially offsetting margin gains, but highlighted ongoing operational efficiencies.</li>\n<li>Regulatory risk is present with the upcoming Florida City Gas rate case, as Moriarty indicated surprise at the regulatory outcome and the need to file a general rate case after unexpected delays.</li>\n<li>Analysts questioned the impact of weather on earnings, customer growth variance across regions, and the ability to achieve planned cost savings from ERP investment.</li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>Chesapeake Utilities closed 2025 with record financial results, strong customer growth, and the achievement of its equity capitalization goal well ahead of schedule. Management reaffirmed its long-term EPS growth targets and capital investment plans while preparing for major technology transformation and regulatory filings in 2026. The company sees continued expansion opportunities in its core and new markets and remains focused on operational efficiency, prudent capital allocation, and engaging with stakeholders to support sustained earnings and dividend growth.</p>\n<p><a href=\"https://seekingalpha.com/symbol/cpk/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4558363-chesapeake-utilities-reaffirms-7_75-8-eps-target-for-2028-as-it-launches-75m-erp",
            "pub_date": "2026-02-27 07:15:59",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4558364",
            "title": "Privia Health targets 19.5% adjusted EBITDA growth for 2026 while expanding national footprint to 24 states",
            "description": "<html><body><p data-eci=\"true\">Earnings Call Insights: Privia Health Group, Inc. (PRVA) Q4 2025  </p>\n<h3>Management View</h3>\n<ul>\n<li>CEO Parth Mehrotra stated that \"Privia Health delivered a very strong 2025 as we continue to execute extremely well and drive growth across our markets.\" He highlighted new provider signings and implementations, with 591 providers added, marking a 12.3% year-over-year increase, and value-based attributed lives rising 22.7% to 1.54 million. Practice collections increased 16.9% for 2025, and adjusted EBITDA for the year grew 38.8% to $125.5 million, with EBITDA margin as a percentage of care margin expanding 480 basis points to 27.2%.</li>\n<li>Mehrotra announced the completion of the Evolent Health ACO business acquisition, adding over 120,000 value-based attributed lives and entry into Arizona with anchor partner IMS. The company deployed $180 million for transactions, ending the year with $480 million in cash.</li>\n<li>He emphasized the company’s position for 2026, projecting approximately 20% EBITDA growth at the midpoint of guidance and an 80% EBITDA to free cash flow conversion, expecting to end 2026 with about $600 million in cash.</li>\n<li>CFO David Mountcastle reported that \"implemented providers grew 130 sequentially from Q3 to reach 5,380 at December 31, an increase of 12.3% year-over-year.\" He added, \"practice collections increasing 9.6% from Q4 a year ago to reach $868.7 million. Adjusted EBITDA... increased 26.4% over the fourth quarter last year to reach $31.5 million, representing 27% of Care Margin.\"</li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li>Management is guiding for implemented providers to increase 10.6% year-over-year to 5,950 by year-end 2026, with attributed lives expected at approximately 1.58 million.</li>\n<li>Practice collections are expected to grow 6.6%, care margin 13%, and adjusted EBITDA to increase 19.5% at a $150 million midpoint for 2026. 80% of full year 2026 adjusted EBITDA is expected to convert to free cash flow as the company becomes a full cash taxpayer.</li>\n<li>Mehrotra indicated no acquisitions are assumed in the 2026 outlook, but stated, \"We expect to continue to actively seek business development deals, both in new and existing markets to continue to grow the business and compound our EBITDA and free cash flow.\"</li>\n</ul>\n<h3>Financial Results</h3>\n<ul>\n<li>For 2025, practice collections increased 16.9% to $3.47 billion, care margin was up 14.4%, and adjusted EBITDA grew 38.8% to $125.5 million. The company ended the year with $479.7 million in cash and no debt.</li>\n<li>The conversion rate from EBITDA to free cash flow reached 130% in 2025. Mountcastle noted, \"we expect to end 2026 with approximately $600 million in cash, assuming no capital deployment for new business development.\"</li>\n<li>All metrics were substantially higher than initial 2025 guidance, reflecting strong execution.</li>\n</ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li>Joshua Raskin, Nephron Research LLC: Asked about tech investments and AI advancements. CEO Mehrotra described five investment buckets, highlighting that \"we are really excited on all potential applications of AI\" and referenced ongoing productivity enhancements and potential for margin improvement.</li>\n<li>Jailendra Singh, Truist Securities: Inquired about practice collection trends and care center locations. Mehrotra clarified that year-over-year nuances, including prior period true-ups and capitation revenue, impacted the figures but emphasized strong provider growth and care margin as key metrics.</li>\n<li>Lisa Gill, JPMorgan Chase &amp; Co: Asked about utilization trends and ACA/Medicaid enrollment changes. Mehrotra explained that ambulatory utilization remains elevated and expected to continue, noting Privia’s diversified model buffers against coverage churn.</li>\n<li>Jeff Garro, Stephens Inc.: Questioned EBITDA to free cash flow conversion trends. Mehrotra reiterated focus on robust free cash flow, with Mountcastle confirming confidence in \"80% or more for 2026\" and the transition to full cash taxpayer status.</li>\n<li>Benjamin Mayo, Leerink Partners LLC: Sought updated perspective on capital deployment. Mehrotra maintained the priority to \"continue to deploy capital to keep compounding the business,\" while also referencing flexibility for stock buybacks if warranted.</li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li>Analysts showed a generally positive and inquisitive tone, focusing on forward growth, capital deployment, and technology enhancements. Many congratulated management on strong results and sought clarity on guidance nuances and market expansion.</li>\n<li>Management remained confident and detailed in responses, often referencing long-term strategy, operational rigor, and cash discipline. Mehrotra’s repeated references to a \"portfolio approach\" and \"compounding EBITDA\" highlight a forward-looking, disciplined optimism.</li>\n<li>Compared to the previous quarter, the management tone in prepared remarks was consistent, but slightly more assertive in outlining capital deployment priorities and the impact of recent acquisitions. Analyst sentiment remained upbeat, with a continued focus on growth levers and risk management.</li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li>The current quarter saw a shift from focusing on 2025 outperformance and guidance raises to emphasizing execution on 2026 targets, acquisitions, and the integration of Evolent Health’s ACO business.</li>\n<li>Guidance for 2026 projects slower practice collections growth (6.6% vs. prior-year double digits) but continued strong EBITDA expansion and cash accumulation.</li>\n<li>Analysts continued to probe on similar themes: provider growth, M&amp;A strategy, utilization trends, and capital allocation. However, more emphasis was placed this quarter on AI strategy and synergy realization from acquisitions.</li>\n<li>Management’s confidence remained high, consistently referencing historical outperformance and compounding growth, but with added detail on capital allocation philosophy and technological enhancements.</li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li>Management cited payer landscape challenges, the need for disciplined risk management in contract structures, and the complexities of integrating acquisitions such as Evolent Health’s ACO business.</li>\n<li>Mehrotra acknowledged, \"there are a lot of companies that are challenged, public and private,\" and indicated a cautious approach to capital deployment and new market entries.</li>\n<li>Analyst questions surfaced concerns over practice collection variability, EBITDA to free cash flow conversion, and the sustainability of elevated utilization trends amid ACA and Medicaid changes.</li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>Privia Health management highlighted robust 2025 operational results, the successful integration of new assets such as the Evolent Health ACO business, and a disciplined capital allocation strategy. With expansion into 24 states, a growing provider base, and technology-enabled efficiency gains, the company projects nearly 20% adjusted EBITDA growth for 2026 and expects to maintain significant cash flexibility to support further business development, even as it navigates evolving payer environments and regulatory challenges.</p>\n<p><a href=\"https://seekingalpha.com/symbol/prva/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4558364-privia-health-targets-19_5-percent-adjusted-ebitda-growth-for-2026-while-expanding-national",
            "pub_date": "2026-02-27 07:15:59",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557930",
            "title": "Here are the major earnings before the open Friday",
            "description": "<html><body><p data-eci=\"true\">Major earnings expected before the bell on Friday include:</p>\n<ul>\n<li>Arbor Realty Trust  (ARR)</li>\n<li>Energy Fuels (UUUU)</li>\n<li>The AES Corporation  (AES)</li>\n<li>Frontline plc  (FRO)</li>\n<li>Globalstar  (GSAT)</li>\n</ul>\n<p>Other earnings slated for release before Friday's open include:</p>\n<ul>\n<li>[[AMR]],   [[AMRX]],   [[ANIP]],   [[AUGO]],   [[BASFY]],   [[CRI]],   [[DCBO]],   [[DK]],   [[DKL]],   [[EC]],   [[EXK]],   [[FLGT]],   [[GLP]],   [[GOGO]],   [[ICAGY]],   [[INTT]],   [[NWN]],   [[PSO]],   [[SHO]],   [[TAC]],   [[TCPC]],   [[YPF]]</li>\n<li>For Seeking Alpha's full earnings season calendar, <a href=\"https://seekingalpha.com/earnings/earnings-calendar\">click here</a>.</li>\n</ul>\n<div class=\"signup_widget_placeholder_news_bottom\"></div></body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557930-here-are-the-major-earnings-before-the-open-friday",
            "pub_date": "2026-02-27 07:01:05",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4558357",
            "title": "Sirius XM unit prices upsized $1.25 billion bond offering",
            "description": "<html><body><ul>\n<li>Sirius XM Holdings (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/SIRI\" title=\"Sirius XM Holdings Inc.\">SIRI</a></span>) said on Thursday its unit, Sirius XM Radio, priced an upsized $1.25 billion offering of 5.875% senior notes due 2032, increasing the deal size by $250 million <a href=\"https://seekingalpha.com/news/4557822-siriusxm-unit-plans-1-billion-senior-notes-offering-due-2032\" target=\"_blank\" title=\"from its earlier plan\">from its earlier plan</a>.</li>\n<li>The notes were priced at par and will bear interest at 5.875% annually.</li>\n<li>The sale is expected to close on or about March 4, 2026, subject to customary conditions.</li>\n<li>The company said it will use the proceeds, along with cash on hand, to buy back any and all of its 3.125% senior notes due 2026 via a concurrent tender offer, redeem any remaining 2026 notes not tendered, and redeem $250 million of its 5.000% senior notes due 2027.</li>\n<li>As of December 31, 2025, $1.0 billion of the 2026 notes and $1.5 billion of the 2027 notes were outstanding, it said.</li>\n<li>FWONA <span>-</span><span>0.41%</span> after hours to $79.63.</li>\n<li>Source: <a href=\"https://seekingalpha.com/pr/20416920-sirius-xm-radio-llc-prices-upsized-offering-of-1250-000000-of-5_875-percent-senior-notes-due\">Press Release</a>\n</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4558357-sirius-xm-unit-prices-upsized-125-billion-bond-offering",
            "pub_date": "2026-02-27 06:56:01",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4558361",
            "title": "Ameren announces pricing of senior notes due 2036",
            "description": "<html><body><ul>\n<li>Ameren (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/AEE\" title=\"Ameren Corporation\">AEE</a></span>) on Thursday announced the pricing of a public offering of $400 million aggregate principal amount of 5.00% senior notes due 2036 at 99.802% of their principal amount.</li>\n<li>The transaction is expected to close on March 4, 2026.</li>\n<li>Ameren intends to use the net proceeds of the offering for general corporate purposes, including to repay a portion of its short-term debt, including short-term debt incurred to refinance Ameren's 3.65% senior notes due 2026 upon maturity.</li>\n<li>Source: <a href=\"https://seekingalpha.com/pr/20416925-ameren-announces-pricing-of-senior-notes-due-2036\">Press Release</a>\n</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4558361-ameren-announces-pricing-of-senior-notes-due-2036",
            "pub_date": "2026-02-27 06:56:01",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        }
    ]
}